08:54 AM EDT, 10/23/2024 (MT Newswires) -- Redwire ( RDW ) said Wednesday it is collaborating with Bristol-Myers Squibb ( BMY ) to evaluate model small molecule compounds in the International Space Station.

Financial terms weren't disclosed.

Under the partnership, the companies will study the compounds using Redwire's ( RDW ) pharmaceutical drug development platform, according to a statement.

Redwire ( RDW ) also said it will be launching a pharmaceutical drug development platform investigation in collaboration with ExesaLibero Pharma to evaluate the drug ELP-004, which prevents excess bone removal associated with different diseases.

Price: 9.05, Change: +0.15, Percent Change: +1.69